| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immucell Corp /de/ (ICCC) has 7 insiders with recent SEC Form 4 filings, including 38 buys and 0 sells. ICCC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 120.0K | $966.0K | - | |
| CEO | 109.5K | $881.5K | - | |
| VP | 100.0K | $805.0K | - | |
| Dir | 11.9K | $96.1K | - | |
| Dir | 11.9K | $96.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2016 | Tomsche David Scott | Director | Buy | 6,666 | $5.25 | $34,996.50 | +11.3% | |
| Nov 11, 2015 | Rothschild Jonathan E | Director, 10% Owner | Buy | 24,000 | $0.00 | - | +5.0% | |
| Sep 14, 2015 | Wainman Paul R | Director | Buy | 175 | $6.80 | $1,189.98 | +9.6% | |
| Sep 3, 2015 | Rothschild Jonathan E | Director, 10% Owner | Buy | 3,000 | $6.63 | $19,881.00 | - | |
| Sep 1, 2015 | Tomsche David Scott | Director | Buy | 1,000 | $6.73 | $6,730.00 | +1.7% | |
| Aug 31, 2015 | Rothschild Jonathan E | Director, 10% Owner | Buy | 6,100 | $7.37 | $44,967.50 | - | |
| Aug 28, 2015 | Tomsche David Scott | Director | Buy | 1,500 | $7.27 | $10,905.00 | +2.6% |